Galderma
Galderma S.A. is an American-Swiss pharmaceutical company specializing in dermatological treatments and skin care products. Formerly a subsidiary of L'Oréal and Nestlé, it has been held by a consortium of private institutional investors since 2019.
| Company type | Private company |
|---|---|
| Industry | Dermatology Pharmaceuticals |
| Founded | 1981 |
| Headquarters | Galderma Pharma SA/Galderma SA Zug, Switzerland. |
Key people | Flemming Ørnskov, CEO |
| Revenue | USD 3.417 billion (2021) |
| Owner | Consortium including EQT, Adia, GIC, PSP Investments |
Number of employees | 5,700 (2021) |
| Website | www.galderma.com |
Galderma was formed in 1981 as a joint venture between Nestlé and L'Oréal, then it became a subsidiary of Nestlé. Since 2019, it belongs to an investment fund. The company, headed by president and CEO Flemming Ørnskov (ex-Shire), has 33 sites in 100 countries with a worldwide network of distributors and employs more than 4,600 people. The headquarters is based in Zug, Switzerland. In 2021, the slogan of Galderma is "Advancing dermatology for every skin story".
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.